Endostar combined with cisplatin inhibits tumor growth and lymphatic metastasis of lewis lung carcinoma xenografts in mice.

To investigate the effects of endostar, a recombined humanized endostatin, plus cisplatin on the growth, lymphangiogenesis and lymphatic metastasis of the Lewis lung carcinoma (LLC) in mice.
A tumor model were established in C57BL/6 mice by intravenious transplantation of LLC cells. Then the mice were randomized to receive administration with NS, endostar, cisplatin, or endostar plus cisplatin. After the mice were sacrificed, tumor multiplicity, tumor size and lymph node metastasis were assessed. Then the expression of vascular endothelial growth factor-c (VEGF-C) and podoplanin were determined by immunohistochemical staining.
Endostar plus cisplatin significantly suppressed tumor growth. lymphatic metastasis and prolonged survival time of the mice without obvious toxicity. The inhibition of lymphatic metastasis was associated with decreased microlymphatic vessel density (MLVD) and expression of VEGF-C.
Endostar combined with cisplatin was more effective to suppress tumor growth and lymphatic metastasis than either agent alone. Thus this may provide a rational alternative for lung carcinoma treatment.
AuthorsXiao-Peng Dong, Tian-Hui Xiao, Hong Dong, Ning Jiang, Xiao-Gang Zhao
JournalAsian Pacific journal of cancer prevention : APJCP (Asian Pac J Cancer Prev) Vol. 14 Issue 5 Pg. 3079-83 ( 2013) ISSN: 1513-7368 [Print] Thailand
PMID23803083 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Endostatins
  • endostar protein
  • Cisplatin
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Antineoplastic Combined Chemotherapy Protocols
  • Apoptosis (drug effects)
  • Blotting, Western
  • Carcinoma, Lewis Lung (drug therapy, mortality, secondary)
  • Cell Proliferation (drug effects)
  • Cisplatin (pharmacology)
  • Endostatins (pharmacology)
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Lymphatic Metastasis
  • Lymphatic Vessels (drug effects, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Survival Rate
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: